Yaupon Therapeutics Inc. Appoints New Management Team

Published: Jul 18, 2011

MALVERN, Pa.--(BUSINESS WIRE)--Yaupon Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today the appointment of nine new management team members. The new management team will strengthen the company’s foundation and drive momentum as it prepares the NDA submission for its propriety gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL).

Back to news